期刊文献+

乙型脑炎病毒E蛋白基因真核表达载体pEGFP-C1-JEV的构建及在BHK-21细胞中表达

Construction of pEGFP-C1-JEV eukaryotic expression vector of E gene from JEV and expression fu- sion protein molecule in BHK-21 cells
原文传递
导出
摘要 目的构建乙脑病毒E蛋白基因片段的真核表达载体pEGFP-C1-JEV,旨在研究E蛋白基因在BHK-21细胞中的瞬时表达情况,为进一步深入研究提供基础资料。方法通过liT—PCR扩增目的基因,酶切并重组后成功构建绿色荧光蛋白标记的pEGrP—C1-JEV重组表达载体,利用脂质体介导将重组质粒转染BHK-21细胞,观察绿色荧光标记蛋白表达情况,同时提取细胞RNA,检查目的基因转录表达情况,并利用免疫组化和Westernblot法检测目的基因表达情况、表达蛋白在细胞中的定位以及表达蛋白抗原性。结果重组质粒pEGrP—C1-JEV构建成功,转染至BHK-21细胞中,绿色荧光标记蛋白正常表达,表达率较高,RT-PCR表明目的基因在BHK-21正常转录并表达,表达蛋白主要分布在BHK-21细胞的胞质和包膜中,且能与豚鼠抗JEV抗体特异性结合。结论pEGFP-C1-JEV质粒在BHK-21细胞中正常表达,且对细胞生长和形态不产生影响,真核表达抗原具有良好的抗原性,本研究可为进一步探讨乙型脑炎E蛋白基因体外真核表达及其功能和应用的研究提供基础资料。 Objective To research the molecular biology characteristics and transient expression in BHK-21 cells of E gene segment from Japanese encephalitis virns(JEV) and construct an eukaryotic ex- pression vector pEGFP-CI-JEV. Methods E gene segment of JEV was amplified by RT-PCR, construct the recombinant vector pEGFP-C1-JEV, which could express EGFP label proteins. Transfect pEGFP-C1-JEV vector into BHK-21 via LipofectAMINETM 2000, to observe expressing of EGFP label protein and tmnscfip- tion of aim gene,and to check up localization and antigenicity of expressed E protein by Immunohistochemis- try and Western blot. Results It showed that the recombinant plasmid pEGFP-C1-JEV was successfully constructed and tran_sfected to BHK-21 cells, the normal expression of green fluorescent protein expression rate was higher. RT-PCR showed that gene transcription in BHK-21 and normal expression, expression pro- tein was mainly distributed in the cytoplasm of BHK-21 cells and the envelope in, and can with guinea pig anti-JEV antibody binding. Conclusion pEGFP-C1-JEV vector in BHK-21 cells was normal expression and there were no effect on cell growth and morphology. Meanwhile, on eukaryotic antigens was good antigeniei- ty. This research as a base foundation for E protein gene of JEV eukaryotic expression and function in vitro and applied research.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2012年第7期600-605,共6页 Chinese Journal of Microbiology and Immunology
基金 甘肃省中青年科技基金计划项目(0806RP/A008)
关键词 乙型脑炎病毒 E蛋白基因 绿色荧光蛋白 真核表达 Japanese encephahtls wrus E gene segment Green fluorescent protein Eukaryotmexpression
  • 相关文献

参考文献15

  • 1Vaughn DW, I4oke CH Jr. The epidemiology of Japanese encepha- litis: prospects for prevention. Epidemiol Rev, 1992, 14: 197- 221.
  • 2Lin CW, Wu SC. A functional epitope determinant on domain Ill of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol, 2003, 77 ( 4 ) : 2600 -2606.
  • 3Kolaskar AS, Kulkami-Kale U. Prediction of three-dimensional structure and mapping of conformational epitopes of envelope gly- coprutein of Japanese encephalitis virus. Virology, 1999, 261(1) : 31-42.
  • 4J.Sambrook.分子克隆实验指南,金冬雁,译.2版.北京:科学出版社,1992:880-887.
  • 5McMinn PC. The molecular basis of virulence of the encephalito- genic flaviviruses. J Gen Virol, 1997, 78 ( Pt 11 ) : 2711-2722.
  • 6Pugachev KV, Guirakhoo F, Trent DW, et al. Traditional and no- vel approaches to flavivirus vaccines. Int J Parasitol, 2003, 33(5-6) : 567-582.
  • 7闫丽萍,华荣虹,亓文宝,周艳君,李国新,于海,姜一峰,田志军,童光志.乙型脑炎病毒E蛋白Ⅰ、Ⅱ结构域抗原表位鉴定[J].中国预防兽医学报,2010,32(1):56-60. 被引量:4
  • 8吴玉水,马文煜,等.日本脑炎病毒基因疫苗的研究进展[J].细胞与分子免疫学杂志,2002,18(5):512-514. 被引量:20
  • 9Wu C J, Huang HW, Tao MH. Induction of cross-protection against two wild-type Taiwan Residents isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine. Vaccine, 2003, 21 (25-26) : 3938-3945.
  • 10张雪寒,何孔旺,俞正玉,郭容利,倪艳秀.乙型脑炎病毒E基因在杆状病毒中的表达及其初步应用[J].中国人兽共患病学报,2007,23(9):873-877. 被引量:4

二级参考文献74

  • 1余晓岚,肖少波,方六荣,胡梦雨,严琳,董晓辉,陈焕春.口蹄疫病毒P1基因在大肠杆菌中的高效表达及其生物活性的初步分析[J].生物工程学报,2005,21(1):163-166. 被引量:18
  • 2张雪寒,何孔旺,郭容利,倪艳秀,王芳,俞正玉.流行性乙型脑炎病毒E基因的克隆、表达及初步应用[J].中国病毒学,2005,20(5):494-497. 被引量:6
  • 3闫国和,粟永萍,王军平,汪代杰,艾国平,王锋超,冉新泽,程天民.重组真核表达载体pEGFP-N1/PDGF-A的构建及真皮干细胞的转染[J].第三军医大学学报,2005,27(20):2005-2008. 被引量:6
  • 4许乐燕,徐闻青.乙型脑炎病毒及疫苗研究进展[J].国际生物制品学杂志,2006,29(6):243-247. 被引量:3
  • 5贾向志 马文煜 李育阳.非常规酵母菌表达系统的研究现状[J].细胞与分子免疫学杂志,1999,15(1):119-119.
  • 6MORAESMP, MAYR G A, MASON P W, et al. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and- mouth disease virus (FMDV) strain A24[J]. Vaccine, 2002, 20(11-12):1631-1639.
  • 7ALEXANDERSEN S,ZHANG Z, DONALDSON A I,et al. The pathogenesis and diagnsis of Foot-and- mouth disease[J]. J Comp Path ,2003, 129:1-36.
  • 8ACHARYA R, FRY E, STUART D, et al. The three-dimensional structure of foot-and-mouth disease virus at 2. 9A resolution[J]. Nature, 1989, 337 (6209):709-716.
  • 9BALAMURUGAN V, RENJI R, SAHA S N, et al. Protective immune response of the eapsid precursor polypeptide (P1)of foot and mouth disease virus type O'produced in Pichia pastoris[J]. Virus Res, 2003, 92:141-149.
  • 10SOMIA N. Gene transfer by retroviral vectors: an overview[J].Methods Mol Biol, 2004, 246: 463-490.

共引文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部